PHIO PHARMACEUTICALS CORP (PHIO)
US71880W4024 - Common Stock
Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)
-Phio’s lead clinical product candidate, PH-762, is the focus of dermatological poster presentation...
Tuesday's pre-market session: top gainers and losers
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Tuesday morning!
Monday's after hours session: top gainers and losers
The regular session of the US market on Monday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Which stocks are experiencing notable movement on Monday?
Top movers in Monday's session
Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells
-Injection in murine tumors shows the compound is well tolerated -Studies support ongoing clinical trial of PH-762 as a neoadjuvant therapy for treatment...
Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)
Phio’s lead clinical product candidate, PH-762, is the subject of three new dermatological posters...
Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)
MARLBOROUGH, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose...
National Spotlight Features Phio’s Innovative RNAi Technology Platform
—Program will be airing on PBS with Dennis Quaid in April —It will also be seen on Fox Business Network MARLBOROUGH, Mass., April 03, 2024 (GLOBE...
PHIO Stock Earnings: Phio Pharma Beats EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Phio Pharma (NASDAQ:PHIO) just reported results for the fourth quarter of 2023....
PHIO Stock Earnings: Phio Pharma Beats EPS for Q4 2023
PHIO stock results show that Phio Pharma beat analyst estimates for earnings per share the fourth quarter of 2023.
Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
– Four sites across the country participating in clinical trial for lead product candidate PH-762 – Two patients have already completed treatment – New...
Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity Research
--Four sites across the U.S. are now engaged in the Phase1b study...
Phio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin Disorders
Phio’s Compound RXI-185 and RXI-231 designed to treat photo-aging and hyperpigmentation...
Phio Pharmaceuticals Announces Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies
--New preclinical data to be presented at Immunotherapy Conference in Germany MARLBOROUGH, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals...
Phio Pharmaceuticals files to sell 4.42M shares of common stock for holders (NASDAQ:PHIO)
Phio Pharmaceuticals filed a prospectus for the resale of 4.4 million shares of common stock by selling stockholders, but it is not an offer to sell.
Phio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross Proceeds
MARLBOROUGH, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers for Wednesday with a breakdown of all the latest news this morning!
Phio Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
Phio Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
MARLBOROUGH, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary...
Phio Pharmaceuticals Announces First US Patient Enrolled in Phase 1B Clinical Trial with Intratumoral PH-762 anti-PD-1 Therapy for Treatment of Skin Carcinomas
MARLBOROUGH, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary...